Compare CAT & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAT | NVS |
|---|---|---|
| Founded | 1925 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7B | 254.8B |
| IPO Year | N/A | 1991 |
| Metric | CAT | NVS |
|---|---|---|
| Price | $583.55 | $139.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 4 |
| Target Price | ★ $588.75 | $118.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.7M |
| Earning Date | 01-29-2026 | 01-30-2026 |
| Dividend Yield | 1.04% | ★ 1.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 19.49 | 7.30 |
| Revenue | ★ $64,671,000,000.00 | $56,372,000,000.00 |
| Revenue This Year | $3.06 | $9.33 |
| Revenue Next Year | $8.15 | $2.75 |
| P/E Ratio | $29.88 | ★ $18.75 |
| Revenue Growth | N/A | ★ 12.88 |
| 52 Week Low | $267.30 | $96.91 |
| 52 Week High | $627.50 | $137.40 |
| Indicator | CAT | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 72.04 |
| Support Level | $557.46 | $134.82 |
| Resistance Level | $627.50 | $137.40 |
| Average True Range (ATR) | 15.94 | 1.78 |
| MACD | -3.90 | 0.55 |
| Stochastic Oscillator | 37.81 | 89.06 |
Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. Its reporting segments are construction, resource, energy, and transportation. Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has a global reach that is approximately evenly balanced between the US and the rest of the world. Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of over 150 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.